The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...

U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices ...

Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires. On ...

Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Boston Scientific has outperformed the broader market over the past year, and analysts are highly optimistic about the ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

Marlborough, Mass.-based Boston Scientific has launched Endura Weight Loss Solutions, a new line of minimally invasive endobariatric procedures such as endoscopic sleeve gastroplasty and Orbera ...

This was the stock's second consecutive day of gains.

Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...

The current consensus estimates for BSX's forthcoming earnings report stand at $0.72 per share on revenue of $4.89 billion.

Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the pandemic period.